Concepedia
Statistics
Publications
13
Citations
462
H-Index
12
Active since
2003
Affiliations
Uppsala University(Current)
AstraZeneca (Sweden)
Affibody (Sweden)
Uppsala University Hospital
AlbaNova
Ann-Charlott Steffen is an author at Uppsala University specializing in medicine, molecular oncology, and oncology.
Publications per year
2003–2013
<i>In Vitro</i> Characterization of a Bivalent Anti-HER-2 Affibody with Potential for Radionuclide-Based Diagnostics
Ann-Charlott Steffen, Maria Wikman, Vladimir Tolmachev et al. · Cancer Biotherapy and Radiopharmaceuticals · 2005 · 102 citations
Medicine, Molecular Biology, Oncology +17
Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β
Simon J. Henderson, Christin Andersson, Rajesh Narwal et al. · Brain · 2013 · 77 citations · Full text
Life Sciences, Neurology, Neuroscience +17
Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice
Ann-Charlott Steffen, Anna Orlova, Maria Wikman et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 65 citations
Medicine, Oncology, Pharmacology +12
Biodistribution of 211At labeled HER-2 binding affibody molecules in mice
Ann-Charlott Steffen, Ylva Almqvist, Ming‐Kuan Chyan et al. · Oncology Reports · 2007 · 35 citations · Full text
Medicine, Molecular Pharmaceutics, Pharmacology +12
Capillary Microsampling and Analysis of 4-µL Blood, Plasma and Serum Samples to Determine Human α-Synuclein Elimination Rate in Mice
O. Jonsson, Ann-Charlott Steffen, Valentina Screpanti Sundquist et al. · Bioanalysis · 2013 · 29 citations
Life Sciences, Biochemistry, Pharmacokinetics +9
1–5 of 13